iodixanol has been researched along with Myocardial Ischemia in 5 studies
iodixanol: dimeric contrast media; structure given in first source
iodixanol : A dimeric, non-ionic, water-soluble, radiographic contrast agent, used particularly in coronary angiography.
Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).
| Excerpt | Relevance | Reference |
|---|---|---|
| "We performed a randomized, prospective, double blind trial comparing the use of the ionic dimer contrast agent ioxaglate 320 (Hexabrix) with the nonionic dimer contrast agent iodixanol 320 (Visipaque) in 618 patients undergoing percutaneous coronary intervention (PCI) for stable or unstable coronary artery syndromes." | 5.10 | A randomized prospective trial of ioxaglate 320 (Hexabrix) vs. iodixanol 320 (Visipaque) in patients undergoing percutaneous coronary intervention. ( Ashton, VJ; Campbell, PG; de Belder, MA; Hall, JA; Price, DJ; Sutton, AG, 2002) |
| "In patients with ischemic heart disease, the administration of contrast agents iodixanol, ioversol and gadobutrol improves (due to the effect of dilution) the aggregation of erythrocytes in vivo, but does not change their deformation ability and the percentage of different morphological forms of erythrocytes (discocytes and ehinocytes) in the blood." | 1.36 | [Aggregation, deformation and morphology of erythrocytes in patients with ischemic heart disease after injection of ioversol, iodixanol and gadobutrol]. ( Firsov, NN; Kiseleva, OA; Shimanovskiĭ, NL; Usenko, AN, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shul'zhenko, LV | 1 |
| Pershukov, IV | 1 |
| Batyraliev, TA | 1 |
| Fettser, DV | 1 |
| Sidorenko, BA | 1 |
| Cho, JY | 1 |
| Jeong, MH | 1 |
| Hwan Park, S | 1 |
| Kim, IS | 1 |
| Park, KH | 1 |
| Sim, DS | 1 |
| Yoon, NS | 1 |
| Yoon, HJ | 1 |
| Park, HW | 1 |
| Hong, YJ | 1 |
| Kim, JH | 1 |
| Ahn, Y | 1 |
| Cho, JG | 1 |
| Park, JC | 1 |
| Kang, JC | 1 |
| Kiseleva, OA | 1 |
| Usenko, AN | 1 |
| Shimanovskiĭ, NL | 1 |
| Firsov, NN | 1 |
| Spiro, AJ | 1 |
| Haramati, LB | 1 |
| Jain, VR | 1 |
| Godelman, A | 1 |
| Travin, MI | 1 |
| Levsky, JM | 1 |
| Sutton, AG | 1 |
| Ashton, VJ | 1 |
| Campbell, PG | 1 |
| Price, DJ | 1 |
| Hall, JA | 1 |
| de Belder, MA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Predictive Value of CHA2DS2-VASC Score and Contrast Volume to Creatinine Clearance Ratio in Relation to Mehran Score for Contrast-Induced Nephropathy In ST- Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention[NCT03266458] | 210 participants (Anticipated) | Observational [Patient Registry] | 2018-01-01 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for iodixanol and Myocardial Ischemia
| Article | Year |
|---|---|
A randomized prospective trial of ioxaglate 320 (Hexabrix) vs. iodixanol 320 (Visipaque) in patients undergoing percutaneous coronary intervention.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Contrast Media; Double-Blind Method; | 2002 |
4 other studies available for iodixanol and Myocardial Ischemia
| Article | Year |
|---|---|
[The role of reduction of glomerular filtration rate in outcomes of drug-eluting stents implantation in patients with ischemic heart disease and chronic kidney disease].
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Contrast Media; Coronary Angiography | 2010 |
Effect of contrast-induced nephropathy on cardiac outcomes after use of nonionic isosmolar contrast media during coronary procedure.
Topics: Acute Kidney Injury; Aged; Biomarkers; Contrast Media; Coronary Angiography; Creatinine; Female; Hem | 2010 |
[Aggregation, deformation and morphology of erythrocytes in patients with ischemic heart disease after injection of ioversol, iodixanol and gadobutrol].
Topics: Aged; Contrast Media; Erythrocyte Aggregation; Erythrocyte Deformability; Erythrocytes; Female; Huma | 2010 |
Resting cardiac 64-MDCT does not reliably detect myocardial ischemia identified by radionuclide imaging.
Topics: Adolescent; Adult; Aged; Cardiac-Gated Imaging Techniques; Contrast Media; Coronary Angiography; Fem | 2013 |